Progyny Inc
NASDAQ:PGNY
Intrinsic Value
Progyny, Inc. is a fertility benefits management company. [ Read More ]
The intrinsic value of one PGNY stock under the Base Case scenario is 42.95 USD. Compared to the current market price of 33.06 USD, Progyny Inc is Undervalued by 23%.
Valuation Backtest
Progyny Inc
Run backtest to discover the historical profit from buying and selling PGNY stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Progyny Inc
Current Assets | 640.4m |
Cash & Short-Term Investments | 371.1m |
Receivables | 241.9m |
Other Current Assets | 27.5m |
Non-Current Assets | 116.2m |
PP&E | 27.8m |
Intangibles | 11.9m |
Other Non-Current Assets | 76.5m |
Current Liabilities | 186m |
Accounts Payable | 125.4m |
Accrued Liabilities | 60.5m |
Non-Current Liabilities | 17.2m |
Other Non-Current Liabilities | 17.2m |
Earnings Waterfall
Progyny Inc
Revenue
|
1.1B
USD
|
Cost of Revenue
|
-849.8m
USD
|
Gross Profit
|
238.8m
USD
|
Operating Expenses
|
-176.6m
USD
|
Operating Income
|
62.2m
USD
|
Other Expenses
|
-147k
USD
|
Net Income
|
62m
USD
|
Free Cash Flow Analysis
Progyny Inc
PGNY Profitability Score
Profitability Due Diligence
Progyny Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Progyny Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
PGNY Solvency Score
Solvency Due Diligence
Progyny Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Progyny Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PGNY Price Targets Summary
Progyny Inc
According to Wall Street analysts, the average 1-year price target for PGNY is 47.6 USD with a low forecast of 43.43 USD and a high forecast of 52.5 USD.
Ownership
PGNY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PGNY Price
Progyny Inc
Average Annual Return | 26.86% |
Standard Deviation of Annual Returns | 49.54% |
Max Drawdown | -61% |
Market Capitalization | 3.2B USD |
Shares Outstanding | 96 110 304 |
Percentage of Shares Shorted | 8.45% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.
Contact
IPO
Employees
Officers
The intrinsic value of one PGNY stock under the Base Case scenario is 42.95 USD.
Compared to the current market price of 33.06 USD, Progyny Inc is Undervalued by 23%.